Parkinsonism:InflAMANTADINEChildren 1 to 9 yearsParkinsonism:BROMOCRIPTINEChildren 9 to 12 years:Acromegaly:Drug-induced Extrapyramidal Symptoms:Hyperprolactinemia-associated Dysfunctions:Route and Dosage 2.5 mg/day with meals. Usual range is 10 to 40 mg/day. If 400 mg/day). to 15 mg/day. 2.5 mg every 2 to 7 days. Usual therapeutic dosage range: 2.5 Initial dose: 1.25 to 2.5 mg/day with meals. May increase by 200 mg/day as a single dose or 100 mg 2 times a day.gradually in 2.5 mg increments. 100 mg 2 times a day (up to 300 mg/day in divided doses). 2 times a day.day with meals. May increase dosage every 2 to 4 weeks by adverse reactions necessitate reduction in dosage, reduce dose day every 3 to 7 days. Usual therapeutic dosage range: 20 to or divided 2 times a day, not to exceed 150 mg/day. 3 days (with food) at bedtime. May increase by 1.25 to 2.5 mg/ uenza A Viral Infection:^ (Symmetrel) Adults^ (Parlodel) Adults: Adults: PO:^ PO: PO: 4.4 to 8.8 mg/kg/day given once daily POPO: 200 mg as a single dose or 100 mg : Initial dose: 1.25 to 2.5 mg for : 100 mg 1 to 2 times/day (up to : Initial dose: 1.25 mg 2 times a^ Adults and children >12 years: Antiparkinsonian Agents^ Adults Adults●: :^ POPOPO^507 : : :
2506_Ch29_502-510.indd 507 2506 Ch 29 502 - 510 .indd 4. DefiThe plan of care should include monitoring for the follow- 1. Risk for injury related to symptoms of Parkinson’s disease or ● ing side effects from antiparkinsonian medications. Nursing 3. Activity intolerance related to side effects of drowsiness, diz-● asterisk (*). 5 Neuroleptic Malignant Syndrome: 2. Hyperthermia related to anticholinergic effect of decreased implications related to each side effect are designated by an 07 30 mg/day. Maximum dosage: 100 mg/day. 4 hours. ANTIPARKINSONIAN AGENTSNURSING IMPLICATIONS FOR ziness, ataxia, weakness, confusion.sweating.drug-induced EPS.TO ANTIPARKINSONIAN AGENTS^ NURSING DIAGNOSES RELATED^ cient knowledge related to medication regimen.^ Adult: PO: 5 mg every 1 10/1/10 9:40:26 AM 0 / 1 / 10 9 : 40 : 26 AM
